Drug Trials Snapshot: TEPMETKO
TEPMETKO is a drug used to treat adult patients with a type of non-small cell lung cancer (NSCLC) which has a specific set of gene alterations and has spread to other parts of the body (metastatic).
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: FDA Source Type: news
More News: Cancer | Cancer & Oncology | Drugs & Pharmacology | Genetics | Lung Cancer | Non-Small Cell Lung Cancer